VINCENT MILANO
CIK 1187159 · PRESIDENT AND CEO · last filed 2026-06-15
VINCENT MILANO is a PRESIDENT AND CEO who has filed 98 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for BCRX, was dated Jun 15, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.26M
7
98
-$2.79M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BCRX | Director | 108,483 | $9.74 | $1.06M | $185.2K | 24 | 2026-06-15 |
| ACRS | Director | 28,896 | $5.33 | $154.0K | $0 | 9 | 2026-06-08 |
| Aceragen, Inc. (ACGN) Delisted | Director | 8,987 | $0.38 | $3.4K | -$1.8K | 1 | 2023-08-11 |
| Aceragen, Inc. (IDRA) Delisted | PRESIDENT AND CEO | 12,271 | $7.22 | $88.7K | $781.5K | 22 | 2022-07-07 |
| Spark Therapeutics, Inc. (ONCE) Delisted | Director | 0 | — | — | $0 | 5 | 2019-12-17 |
| VNDA | Director | 10,000 | $5.16 | $51.6K | $0 | 9 | 2018-06-15 |
| VIROPHARMA INC (VPHM) Delisted | President and CEO | 450,898 | — | — | -$3.75M | 25 | 2014-01-21 |
Recent Filings
98 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-15 | BCRX | Grant (A) | +15,294 | $0 | EDGAR |
| 2026-06-08 | ACRS | Mixed | +11,580 | $0 | EDGAR |
| 2026-06-02 | BCRX | Grant (A) | +1,122 | $10.0K | EDGAR |
| 2026-03-03 | BCRX | Grant (A) | +848 | $7.4K | EDGAR |
| 2025-12-02 | BCRX | Grant (A) | +783 | $5.6K | EDGAR |
| 2025-09-03 | BCRX | Grant (A) | +676 | $5.6K | EDGAR |
| 2025-06-16 | BCRX | Grant (A) | +12,500 | $0 | EDGAR |
| 2025-06-09 | ACRS | Mixed | +4,793 | $0 | EDGAR |
| 2025-06-03 | BCRX | Grant (A) | +523 | $5.6K | EDGAR |
| 2025-03-04 | BCRX | Grant (A) | +653 | $5.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.